UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 9, 2015

 

Health Insurance Innovations, Inc.

(Exact name of registrant as specified in its charter)

 

 

  Delaware

 001-35811

 46-1282634

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

   

15438 N. Florida Avenue, Suite 201

Tampa, Florida

33613
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (877) 376-5831

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

Item 2.02.           Results of Operations and Financial Condition.

 

On November 9, 2015, Health Insurance Innovations, Inc. (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2015. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information furnished in this Item 2.02, including Exhibit 99.1, is not deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

 

Item 7.01.           Regulation FD Disclosure.

 

On November 9, 2015, the Company issued a press release announcing the promotion of Mr. McNamee to the position of Chief Executive Officer. A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.

 

The information furnished in this Item 7.01, including Exhibit 99.2, is not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and it shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent, if any, expressly set forth by specific reference in such filing.

 

Item 9.01.           Financial Statements and Exhibits.

 

(d)             Exhibits.
   
Exhibit Number Description
   
99.1 Press Release, dated November 9, 2015
   
99.2 Press Release of the Company announcing the promotion of Patrick R. McNamee to Chief Executive Officer, dated November 9, 2015.

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEALTH INSURANCE INNOVATIONS, INC.
       
  By: /s/ Angela P. Bryant  
    Name: Angela P. Bryant  
    Title:    Senior Vice President, General Counsel

 

Date: November 9, 2015

 

 

 

 
 

EXHIBIT INDEX

 

 

Exhibit Number Description
   
99.1 Press Release, dated November 9, 2015
   
99.2 Press Release of the Company announcing the promotion of Patrick R. McNamee to Chief Executive Officer, dated November 9, 2015.